These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2776842)

  • 1. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
    Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
    Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
    Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
    Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
    Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A
    Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
    Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
    J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y is a vasoconstrictor of human coronary arteries.
    Tseng CJ; Robertson D; Light RT; Atkinson JR; Robertson RM
    Am J Med Sci; 1988 Jul; 296(1):11-6. PubMed ID: 3407677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
    Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
    J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
    Prieto D; Simonsen U; Nyborg NC
    Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction.
    Martin SE; Tidmore WC; Patterson RE
    Am J Physiol; 1991 Jun; 260(6 Pt 2):H1753-9. PubMed ID: 2058714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
    Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
    Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
    Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
    Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neuropeptide Y on double-peaked constrictor responses to periarterial nerve stimulation in isolated, perfused canine splenic arteries.
    Yang XP; Chiba S
    Jpn J Pharmacol; 2000 Jan; 82(1):67-70. PubMed ID: 10874591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
    Han C; Abel PW
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
    Otani N; Yang T; Levy MN
    Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
    Hieble JP; Duesler JG; Daly RN
    J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers.
    Martin SE; Patterson RE
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H927-34. PubMed ID: 2506768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y potentiates contractile response to norepinephrine in skate coronary artery.
    Bjenning C; Holmgren S; Farrell AP
    Am J Physiol; 1993 Aug; 265(2 Pt 2):H661-5. PubMed ID: 8368368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.
    Prieto D; Benedito S; Simonsen U; Nyborg NC
    Br J Pharmacol; 1991 Mar; 102(3):754-8. PubMed ID: 1364848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neuropeptide Y on isolated rat hearts.
    Jolly SR; Ordoukhani A; Movahed A
    Pharmacology; 1991; 43(3):121-7. PubMed ID: 1775516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic coronary tone during submaximal exercise in the dog is produced by circulating catecholamines. Evidence for adrenergic denervation supersensitivity in the myocardium but not in coronary vessels.
    Chilian WM; Harrison DG; Haws CW; Snyder WD; Marcus ML
    Circ Res; 1986 Jan; 58(1):68-82. PubMed ID: 3002658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.